Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Option Award | 2024-04-17 4:15 pm | N/A 2034-04-15 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 367,300 | $0 | 367,300 (Direct) | View |
| 2023-04-14 Option Award | 2023-04-18 7:50 pm | N/A 2033-04-14 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 194,200 | $0 | 194,200 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-01 4:13 pm | N/A 2032-04-19 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 48,350 | $0 | 48,350 (Direct) | View |
| 2022-04-19 Option Award | 2022-04-20 4:30 pm | N/A 2032-04-19 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 48,350 | $0 | 48,350 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-01 8:52 pm | N/A 2032-01-31 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Executive VP, Research | 21,842 | $3 | 23,058 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 4:38 pm | N/A 2031-04-19 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 26,050 | $0 | 26,050 (Direct) | View |